Dror Ben-Asher Photo: Arik Soltan RedHill Biopharma raises $20m on Nasdaq

The Israeli company will use the funds for the commercial launch of H.pylori drug TALICIA and two phase III clinical trials.

Omar Ishrak in Israel Photo: Chen Damari Medtronic CEO attends Tel Aviv conference

Omar Ishrak was a guest of honor at the International Conference for Innovations in Cardiovascular Systems.

medical cannabis Cannbit to sell medical cannabis to Tikun Olam

Tikun Olam will be short of cannabis until its Kfar Yehoshua farms is approved.

cannabis  photo: Kfir Ziv Medical cannabis export bill passes first Knesset reading

Even if the bill passes until law, its implementation will still depend on Prime Minister Benjamin Netanyahu giving the green light.

 Omar Ishrak Photo: Reuters Medtronic CEO visits Israel

Omar Ishrak heads a delegation of senior executives who will become acquainted with Medtronics recent acquisitions - Mazor Robotics, Nutrino and Visionsense.

Elisabeth Kogan Photo: PR Teva's loss is Israeli pharma industry's gain

Disinvestment by Teva from Israeli companies and thousands of employees laid off have had advantages for Israel's pharma industry, including successful startups.

Medical cannabis Photo: Shutterstock The state of medical cannabis

"Globes" surveys Israel's medical cannabis sector, in which  more than 100 companies are already operating.

Maurice Ferre Photo: PR Insightec CEO confident of $30-50 billion exit

Maurice Ferré says that the Israeli company's medical device technology is a game changer in incisionless surgery.

Kare Schultz Photo: PR Teva sacrifices long-term growth for stability

One year into the job, Teva CEO Kare Schultz has halted the plunge in the company's share price and restored investor confidence, but what of the future?

Participants at Tel Aviv cannabis conference Photo: PR "Canadians have given up on Israeli cannabis exports"

DLA Piper Canada partner Adv. Noam Goodman and iCan founder Saul Kaye speak to "Globes" about the cannabis opportunities Israel is missing.

Aharon Lutzky "Next for Tikun Olam: A cannabis pharmacy"

CEO Aharon Lutzky talks about the $400 million medical cannabis company's special business model, and its ambitions.

8400 Dr. Yair Schindel and Daphna Murvitz Photo: Shlomi Yosef Exclusive program launched for medical industry leaders

The 8400 project aims to do for Israel's healthcare industry what the IDF's 8200 unit has done for cybersecurity.

Slimming Photo: Shutterstock 8 Israeli startups offer original ways to lose weight

Israeli medical companies are tackling the problem of obesity.

Prof. Moshe Shoham Photo: Paul Orlive Mazor founder has more startups in the pipeline

Medtronic is buying Prof. Moshe Shoham's Mazor for $1.6 billion, while he is looking forward to more robots and more startups.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018